Vice President of Business Development
Revalia Bio
Vice President of Business Development
Revalia Bio
Ex vivo organ research platform services
Revalia is generating the human data that AI models of human biology need. We keep donated, non-transplantable human organs functioning on our proprietary perfusion technology and measure how they behave and respond to medicines, producing data that is not available from other sources.
We are building this data to train AI models of human biology, with the aim of making drug discovery faster, safer and less costly. Our perfusion data is already becoming part of biopharma programs built on new approach methodologies (NAMs), and it supports IND filings and decisions to begin human clinical trials.
A Yale spinout headquartered in New Haven, CT, we are backed by $20M in venture funding and $30M in government contracts, including an ARPA-H award.
The VP of Business Development will lead Revalia Bio's business development and sales activities with pharmaceutical and biotechnology companies. As the company's first dedicated commercial leader, this person will be responsible for customer engagement, contract negotiation and pricing, and for building the commercial team as the business grows.
This person will also help bring new offerings to market, including data licensing and AI-based products, and shape partnership structures beyond traditional fee-for-service agreements. The role combines established sales responsibilities with early-stage business development.
What you bring
New Haven, CT or Indianapolis, IN preferred; remote considered with roughly 25% travel. Expected base salary is $200,000 to $275,000 USD plus meaningful equity and bonus, with competitive benefits (health, dental, vision, retirement, disability, wellness stipend) from day one.
We look for people who live our values: world-class collaboration, cultivating deep trust, relentless adaptability, and persevering with uncommon grit.
Revalia Bio acknowledges and celebrates the diversity of our workforce, is dedicated to creating an equitable workplace, and aims to create a culture where every individual feels a sense of belonging. We are an equal opportunity employer and do not discriminate on the basis of race, religion, color, national origin, sex, sexual orientation, gender, gender identity or expression, age, disability, or genetic makeup. To request accommodations, please email [email protected].
Revalia Bio is an equal opportunity employer.
[{'location': 'Revalia HQ', 'currency': 'USD', 'frequency': 'YEAR', 'rangeStart': 200000.0, 'rangeEnd': 275000.0, 'isRemote': False}, {'location': 'Remote (United States)', 'currency': 'USD', 'frequency': 'YEAR', 'rangeStart': 200000.0, 'rangeEnd': 275000.0, 'isRemote': True}]
Ex vivo organ research platform services
Revalia Bio uses an ex vivo human organ research platform to provide contract research services for the biopharmaceutical industry. The platform lets researchers study human organs outside the body in a controlled setting, enabling evaluation of drug targets, optimization of lead compounds, and preclinical development across diseases like cancer, cardiovascular, and infectious diseases. Unlike traditional models that rely on non-human systems, Revalia Bio focuses on human organ tissue to generate data that can faster inform drug development. The company differentiates itself through its specialized ex vivo organ platform and services (target validation, lead optimization, preclinical studies) offered as contract research. Its goal is to shorten the drug development timeline and reduce costs by providing human-organ–based testing to pharmaceutical and biotech clients.
Explore more opportunities at Revalia Bio